Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.47 |
| ▸ | GCLC | P48506 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.46 |
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 5/20 | 0.45 |
| ▸ | NOS3 | P29474 | 3/20 | 0.44 |
| ▸ | NOS2 | P35228 | 3/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ARG1 | P05089 | 3/20 | 0.42 |
| ▸ | ARG2 | P78540 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Buthionine Sulfoxime SCHEMBL9300391 | 1.00 | PMP22 (0.59) | PMP22DDAH1GCLCSLC1A2SLC1A1 | |
| Buthionine Sulfoxime SCHEMBL115963 | 1.00 | PMP22 (0.59) | PMP22DDAH1GCLCSLC1A2SLC1A1 | |
| Buthionine Sulfoxime SCHEMBL62034 | 1.00 | PMP22 (0.59) | PMP22DDAH1GCLCSLC1A2SLC1A1 | |
| Buthionine Sulfoxime SCHEMBL4449935 | 1.00 | PMP22 (0.59) | PMP22DDAH1GCLCSLC1A2SLC1A1 | |
| Buthionine Sulfoxime SCHEMBL121171 | 1.00 | PMP22 (0.59) | PMP22DDAH1GCLCSLC1A2SLC1A1 | |
| Buthionine Sulfoximine SCHEMBL28249466 | 0.98 | PMP22 (0.58) | PMP22DDAH1GCLCSLC1A2SLC1A1 | |
| SCHEMBL13746032 | 0.89 | PMP22 (0.63) | PMP22DDAH1GCLCSLC1A2SLC1A1 | |
| SCHEMBL5904143 | 0.89 | PMP22 (0.63) | PMP22DDAH1GCLCSLC1A2SLC1A1 | |
| SCHEMBL21965593 | 0.86 | PMP22 (0.50) | PMP22DDAH1GCLCSLC1A2SLC1A1 | |
| SCHEMBL27254997 | 0.86 | PMP22 (0.42) | PMP22DDAH1GCLCSLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11514 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630593-B2 | Method of killing leukemia cells by administration of recombinant'Y3 proteins | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-05-19 | — | — | US | claimed |
| EP-4739299-A1 | MODELS OF CONE PHOTORECEPTOR DEGENERATION | SORBONNE UNIVERSITE (FR) | 2026-05-13 | — | — | EP | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260034094-A1 | COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS | KOJIN THERAPEUTICS INC (US) | 2026-02-05 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-20250381202-A1 | PRODRUG KIT FOR MULTI-PRONGED CHEMOTHERAPY | ZOUNEK ALEX (DE) | 2025-12-18 | — | — | US | claimed |
| EP-4661876-A1 | METABOLIC INHIBITORS AND METHODS OF MAKING AND USING THEREOF | University of Miami (US) | 2025-12-17 | — | — | EP | claimed |
| US-12383529-B2 | Pharmaceutical combination for the treatment of cancer | Piramal Enterprises Limited (IN) | 2025-08-12 | — | — | US | claimed |
| EP-4565228-A2 | COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS | Kojin Therapeutics, Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| US-20250161297-A1 | COMPOSITIONS AND METHODS FOR INHIBITING FSP1 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-05-22 | — | — | US | claimed |
| WO-1994020068-A1 | COMPOSITION AND METHOD FOR WHITENING SKIN | YALE UNIVERSITY (US) | 1994-09-15 | — | — | WO | claimed |
| WO-1993025705-A9 | METHOD AND KIT FOR TESTING TUMORS FOR DRUG SENSITIVITY | — | 1994-03-31 | — | — | WO | claimed |
| WO-1993025705-A1 | METHOD AND KIT FOR TESTING TUMORS FOR DRUG SENSITIVITY | BARRANCO SAM C III (US) | 1993-12-23 | — | — | WO | claimed |
| WO-1993020195-A1 | METHOD AND RECOMBINANT CELLS FOR PROVIDING INCREASED RESISTANCE OF HEMATOPOIETIC PROGENITOR CELLS TO TOXICITY OF CHEMOTHERAPEUTIC AGENTS | FOX CHASE CANCER CENTER (US) | 1993-10-14 | — | — | WO | claimed |
| EP-0269017-B1 | THERAPEUTIC COMBINATION OF FREE-RADICAL SCAVENGER OR METABOLIC INHIBITOR AND BIOLOGICALLY ACTIVE PROTEIN | CETUS ONCOLOGY CORPORATION (US) | 1992-07-29 | — | — | EP | claimed |
| US-5091385-A | Destroys tumors or other biological contaminants infecting animals | BAYLOR RESEARCH INSTITUTE (US) | 1992-02-25 | — | — | US | claimed |
| EP-0436642-A1 | PRE-ACTIVATED THERAPEUTIC AGENTS DERIVED FROM PHOTOACTIVE COMPOUNDS. | BAYLOR RES FOUND (US) | 1991-07-17 | — | — | EP | claimed |
| WO-1990003187-A1 | PRE-ACTIVATED THERAPEUTIC AGENTS DERIVED FROM PHOTOACTIVE COMPOUNDS | BAYLOR RESEARCH FOUNDATION (US) | 1990-04-05 | — | — | WO | claimed |
| US-4867962-A | Functionally specific antibodies | NEORX CORPORATION (US) | 1989-09-19 | — | — | US | claimed |
| EP-0330201-A2 | Method of enhancing the effect of cytotoxic agents | NEORX CORPORATION (US) | 1989-08-30 | — | — | EP | claimed |